Edition:
United States

Easywell Biomedical Inc (1799.TWO)

1799.TWO on Gre Tai Securities Market of Chinese Taipei

23.50TWD
2 Dec 2016
Change (% chg)

NT$-1.30 (-5.24%)
Prev Close
NT$24.80
Open
NT$23.60
Day's High
NT$24.45
Day's Low
NT$23.50
Volume
338
Avg. Vol
91,227
52-wk High
NT$38.13
52-wk Low
NT$20.10

1799.TWO

Chart for 1799.TWO

About

Easywell Biomedical Inc. is a Taiwan-based company principally engaged in the research and development, production and sales of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal... (more)
No analyst recommendations are available for 1799.TWO.

Overall

Beta: 0.63
Market Cap(Mil.): NT$1,399.80
Shares Outstanding(Mil.): 65.41
Dividend: --
Yield (%): --

Financials

  1799.TWO Industry Sector
P/E (TTM): -- 32.25 29.87
EPS (TTM): -2.51 -- --
ROI: -19.98 13.46 14.95
ROE: -18.95 17.16 16.29

BRIEF-Easywell Biomedical unit completes pilot SAD pharmacokinetic clinical study of parkinson treatment

* Says its 50.2-percent-owned unit completed pilot SAD pharmacokinetic clinical study of parkinson treatment in Malaysia

Nov 29 2016

Earnings vs. Estimates

No consensus analysis data available.